Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 7 November 2023 30 November 2024 30 November 2024 15265665 Dr SUFYAN PATEL iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15265665 2023-11-06 15265665 2024-11-30 15265665 2023-11-07 2024-11-30 15265665 frs-core:CurrentFinancialInstruments 2024-11-30 15265665 frs-bus:PrivateLimitedCompanyLtd 2023-11-07 2024-11-30 15265665 frs-bus:FilletedAccounts 2023-11-07 2024-11-30 15265665 frs-bus:Micro-entities 2023-11-07 2024-11-30 15265665 frs-bus:AuditExempt-NoAccountantsReport 2023-11-07 2024-11-30 15265665 frs-bus:Director1 2023-11-07 2024-11-30
Registered number: 15265665
Sufs Medical Ltd
Unaudited Financial Statements
For the Period 7 November 2023 to 30 November 2024
UK TAX MATTERS LONDON LIMITED
Balance Sheet
Registered number: 15265665
30 November 2024
£
Fixed assets 11,250
Current assets 75,590
Creditors: Amounts Falling Due Within One Year (30,413 )
NET CURRENT ASSETS 45,177
TOTAL ASSETS LESS CURRENT LIABILITIES 56,427
NET ASSETS 56,427
CAPITAL AND RESERVES 56,427

Notes

1. General Information
Sufs Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15265665 . The registered office is 128 City Road, London, EC1V 2NX.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
Page 0
Page 1
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr SUFYAN PATEL
Director
10/02/2025